Drug
Daidzein
Daidzein is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
100%(1 trials)
Phase Distribution
Ph phase_2
1
33%
Ph not_applicable
2
67%
Phase Distribution
0
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(1)
Other(1)
Detailed Status
unknown1
Not yet recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 21 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown133%
not_yet_recruiting133%
completed133%
Recent Activity
0 active trials
Showing 3 of 3
not_yet_recruitingphase_2
Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD
NCT07623044
completednot_applicable
The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids
NCT00951912
unknownnot_applicable
Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women
NCT01270737
Clinical Trials (3)
Showing 3 of 3 trials
NCT07623044Phase 2
Effects of Short-term Perioperative Daidzein Intervention on Liver Histopathology in Patients With MASLD
NCT00951912Not Applicable
The Effects of Soy Isoflavones to Improve the Metabolism of Glucose and Lipids
NCT01270737Not Applicable
Whole Soy and Daidzein on Reduction of Blood Pressure in Postmenopausal Chinese Women
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3